January 14, 2010 at 00:32 AM EST
(CELG) Celgene Corporation Announces Good News for Cancer Drug Study
Yesterday, Celgene Corporation (CELG) announced that its cancer drug Revlimid met the main goal in a randomized, double-blind, multi-center late-stage study (IFM 2005 02). The study, sponsored by the Intergroupe Francophone du Myelome and University Hospital of Toulouse, evaluated Revlimid compared to placebo in patients suffering from multiple myeloma (MM) who had undergone an autologous [...] (CELG) Celgene Corporation Announces Good News for Cancer Drug Study
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here